BamSEC and AlphaSense Join Forces
Learn More

Fate Therapeutics Inc. – Insider Transactions

NASDAQ: FATE    
Share price (9/22/26): $2.58    
Market cap (9/22/26): $309 million

Recent Insider Transactions

Date Owner Type Security Price Units Value
12/34/56 Tahl Cindy   See Remarks S Common Stock $0.00 0.00 $0
12/34/56 Valamehr Bahram   President and CEO S Common Stock $0.00 0.00 $0
12/34/56 Xu Yuan A Stock Option (Right to Buy) $0.00 0.00 $0
12/34/56 Jooss Karin A Stock Option (Right to Buy) $0.00 0.00 $0
12/34/56 Epstein Robert S A Stock Option (Right to Buy) $0.00 0.00 $0